These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1493666)

  • 1. [The efficacy and tolerance of heparin-calcium at low doses in postinfarct ischemic cardiopathy].
    Melina D; Guerrera G; Melina G; Guerrera C
    Clin Ter; 1992 Dec; 141(12):447-56. PubMed ID: 1493666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic evaluation of silent ischemia during exercise in patient with recent infarction. Italian multicenter study. SMISS Group].
    Vona M; Ignone G; Douard H; Scardi S; Comazzi F
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):121-30. PubMed ID: 10830088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
    Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
    Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low-molecular-weight heparin in unstable angina pectoris].
    Ocampo S; Solorio S; Rangel A; León FJ; Lepe L; Ayala F; Madrid R; Romero MA; Carrillo AM
    Arch Inst Cardiol Mex; 1999; 69(3):222-7. PubMed ID: 10529855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
    Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
    Wang TY; Chen AY; Alexander KP; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Am J Med; 2008 Sep; 121(9):805-10. PubMed ID: 18724971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].
    Savenkov MP; Borshchevskaia MV; Gvozdkov AL; Semenova EN
    Ter Arkh; 1996; 68(8):8-12. PubMed ID: 9019842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].
    Murena E; Molero U; Moio N; Pisani A; Stingone MA; Guardascione A; Grassia V; Scilla C; Marino A; Sibilio G
    Ital Heart J Suppl; 2001 Jul; 2(7):775-82. PubMed ID: 11508296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uncomplicated acute myocardial infarction -- when should the patient be discharged?].
    Ribeiro A; Moura P; Azevedo L; Ferrão B; Marques A; Lopes MA
    Rev Port Cardiol; 2001 Nov; 20(11):1103-6. PubMed ID: 11826701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.